Becton Dickinson (BD) is a leader in healthcare technology, with a strong focus on microbiology and specimen collection systems. In the field of microbiology, BD develops solutions for culture and infection identification, with advanced systems for clinical laboratories. In the Medical and Vacutainer sector, BD provides tubes and needles for biological fluid sampling, designed to ensure safety and precision in analysis. Its products are used globally to improve diagnostics and infection management.

Abbott is a global multinational health care company with a strong presence in in vitro diagnostics and medicine. The company is renowned for its advanced diagnostic tests, with a focus on immunology. Abbott develops and manufactures a wide range of immunoassays, including those for the detection of infectious diseases, oncology, autoimmune diseases, and for monitoring cardiovascular and metabolic diseases. Using innovative technologies such as chemiluminescence and the Alinity platform, Abbott tests offer rapid and accurate results, supporting healthcare professionals in the diagnosis and management of diseases.

Meridian Bioscience is a company specializing in the production of in vitro diagnostic (IVD) solutions. The company offers a wide range of rapid tests, reagents and instruments for the diagnosis of infectious diseases, with a focus on immunological and molecular tests. Its products are designed to ensure accurate and timely results, supporting laboratories and health professionals in disease diagnosis and management.

Sebia is a leading in vitro diagnostics company with a special focus on electrophoresis and hematology. The company is known for its advanced solutions in capillary electrophoresis, used for the analysis and separation of proteins, hemoglobins, and other biomolecules. Sebia develops highly specialized diagnostic systems for applications in oncology, rare diseases, hematology, and genetics, using molecular techniques such as PCR for the detection of genetic mutations. Its products offer high accuracy and reliability in the diagnosis and monitoring of diseases, helping to improve patient health management.

Siemens Healthineers is one of the leading companies in the in vitro diagnostic (IVD) industry, offering advanced solutions for medical diagnostics. In IVD, Siemens develops instruments and systems for the analysis of biological samples, including automated devices for laboratory examinations, diagnostic tests, and imaging solutions. Its products are designed to improve accuracy and efficiency in disease diagnosis, supporting hospitals and laboratories worldwide in health management and personalized medicine.

Genesis is a microbiological diagnostics company with a strong focus on the identification of carbapenemases, enzymes that confer resistance to carbapenem antibiotics, often associated with multidrug-resistant (MDR) bacteria. The company develops advanced solutions for the rapid and accurate detection of carbapenemases, using technologies such as PCR and mass spectrometry assays to identify various types of carbapenemases (such as KPC, NDM, OXA-48). Its products are designed to support microbiology laboratories in diagnosing infections caused by antibiotic-resistant bacteria, improving the management of nosocomial infections and resistance control.

Anatolia is a company specializing in in vitro diagnostics with a strong focus on molecular biology. The company develops and produces innovative solutions for the detection of pathogens, infectious diseases, and genetic conditions using advanced molecular techniques, such as PCR (polymerase chain reaction). Anatolia offers a range of diagnostic tests for DNA, RNA and genetic mutation analysis, supporting laboratories and clinics in the early detection and monitoring of infectious, oncological and genetic diseases. Anatolia products are known for their high accuracy, reliability, and speed of results.

Helitec is a company specializing in microbiological diagnostics, with a special focus on the detection of Mycoplasma infections. The company develops advanced solutions for Mycoplasma diagnosis using molecular techniques, such as PCR, and specific immunoassays. Its products are designed to rapidly identify Mycoplasma pneumoniae, Mycoplasma genitalium, and other Mycoplasma species, which can cause respiratory, urogenital, and other clinical conditions. Helitec’s solutions are used in microbiological and clinical laboratories to ensure accurate and timely diagnoses, improving the management of Mycoplasma infections.

Dirui is a company specializing in the manufacture of in vitro diagnostic (IVD) devices and reagents, with a particular focus on urinalysis. The company offers a wide range of automated systems and reagents for urine tests, used in the detection of chemical, hematological and microbiological abnormalities. Dirui’s products are designed to ensure rapid and accurate results, supporting laboratories and clinics in the diagnosis of kidney disease, urinary infections, and other urinary system-related disorders.

Graso is a company specializing in microbiological diagnostics, with a focus on producing solutions for the detection and identification of bacterial pathogens, fungi, and other microorganisms responsible for infections. The company develops and supplies reagents, kits, and automated systems for microbiological culture, diagnosis of clinical infections, and determination of antibiotic sensitivity (antibiogram testing). Graso also offers solutions for the isolation and identification of microorganisms from clinical specimens, using advanced technologies to ensure rapid, accurate, and reliable results, supporting laboratories in managing infectious diseases and improving the effectiveness of treatments.

Diasys is a company specializing in the production of in vitro diagnostic (IVD) solutions, with a focus on clinical chemistry. The company develops a wide range of reagents and automated systems for biochemical analysis, focusing on tests for the evaluation of blood parameters such as blood glucose, cholesterol, electrolytes, liver enzymes, kidney and other metabolic conditions. Diasys products are designed to ensure highly accurate and rapid results, used primarily in clinical laboratories for the diagnosis, monitoring, and management of metabolic, cardiovascular, and renal diseases.

Diasorin is a prominent company in the field of in vitro diagnostics (IVD), with a special focus on immunology. The company develops and produces a wide range of unique immunological tests, using advanced technologies such as chemiluminescence to detect specific biomarkers. Among the distinctive tests offered by Diasorin are those for the diagnostics of infectious diseases (e.g., HIV, hepatitis, COVID-19) and for the evaluation of autoimmune, oncological, and endocrine diseases. In addition, Diasorin is known for its innovative tests in the field of precision medicine, such as those for determining hormone levels and tumor markers, which support healthcare professionals in monitoring and managing diseases.

Thermo Fisher Scientific is a global leader in microbiology, offering advanced solutions for the detection and diagnosis of infectious diseases, with a strong commitment to IVD (in vitro diagnostics). The company particularly specializes in molecular diagnostics, using technologies such as PCR (polymerase chain reaction) to accurately and rapidly identify bacterial, viral, and fungal pathogens. Its solutions are widely used in clinical testing laboratories, which need high-precision instruments to perform diagnostic tests.

Thermo Fisher also provides rapid tests and specialized reagents that optimize the efficiency of IVD laboratories, enabling timely and reliable diagnoses. These tools help monitor and diagnose infectious diseases, reducing wait times for results and improving access to treatment. Testing laboratories can rely on integrated solutions that simplify sample management and test preparation, thus streamlining daily operations.

In addition, the company supports personalization of care through its innovative technology offerings, helping healthcare professionals make informed and timely decisions. Thermo Fisher continuously strives to improve the accuracy and speed of diagnostic tests, meeting the growing needs of IVD laboratories and the global healthcare industry.